Q3 FY2026 · ended Sep 30, 2026 · Revenue $66,000, +57.1% YoY · Filed Nov 5, 2026
Envoy Medical, Inc. (COCH) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $66,000 and a net loss of $3.9 million. Free cash flow was -$5.1 million.
Revenue
$66,000
+57.1% vs year-ago quarter
Net income
$-3.93M
+39.3% vs year-ago quarter
Operating cash flow
$-5.03M
-16.1% vs year-ago quarter
Free cash flow
$-5.06M
-16.8% vs year-ago quarter
EPS
$-0.50
+85.9% vs year-ago quarter
Dividend per share
None
Shares outstanding
7.74M
-73.1% vs year-ago quarter
Net cash
$2.82M
Q4 FY2025
Operating margin
-10343.3%
TTM
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- COCH (Nasdaq), COCHW (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- White Bear Lake, MN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1840877
- Former names
- Anzu Special Acquisition Corp I (until Sep 29, 2023)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $66,000 | $51,000 | $39,000 | $75,000 | $42,000 |
| Operating income | -$5.5M | -$5.6M | -$6.0M | -$6.8M | -$5.3M |
| Net income | -$3.9M | -$6.0M | -$4.4M | -$6.6M | -$6.5M |
| Diluted EPS | -$0.50 | -$0.07 | -$0.08 | -$0.09 | -$3.55 |
| Operating cash flow | -$5.0M | -$5.5M | -$6.1M | -$5.7M | -$4.3M |
| Free cash flow | -$5.1M | -$5.5M | — | -$5.9M | -$4.3M |
| Total assets | $19.2M | $23.9M | $29.8M | $8.6M | $8.2M |
| Total liabilities | $20.3M | $20.3M | $19.3M | $20.3M | $15.7M |
| Stockholders' equity | -$1.5M | $3.3M | $10.2M | -$12.2M | -$7.7M |
| Cash and investments | $14.6M | $19.7M | $25.3M | $3.7M | $3.6M |
| Total debt | — | — | — | $919,000 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 27, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 16, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Other events
|
Oct 7, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2026 | Aug 24, 2026 |
All 330 Envoy Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.